Clinical Benefits of Piperacillin/Tazobactam versus a Combination of Ceftriaxone and Clindamycin in the Treatment of Early, Non-Ventilator, Hospital-Acquired Pneumonia in a Community-Based Hospital

PURPOSE: There is an increasing prevalence of multidrug-resistant (MDR) organisms worldwide. Therefore, broad-spectrum antibiotics are recommended in the treatment of hospital-acquired pneumonia (HAP). However, it remains controversial whether patients with early onset, non-ventilator HAP (NV-HAP) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ga Eun, Ko, Jae-Hoon, Ki, Hyun Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522409/
https://www.ncbi.nlm.nih.gov/pubmed/33061539
http://dx.doi.org/10.2147/IJGM.S271301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522409/
https://www.ncbi.nlm.nih.gov/pubmed/33061539
http://dx.doi.org/10.2147/IJGM.S271301

Ejemplares similares